Sustained release formulations comprising lamotrigine

Details for Australian Patent Application No. 2003260336 (hide)

Owner Glaxo Group Limited

Inventors Currie, Robin; Maleki, Mehran; Parr, Alan Frank; Buxton, Ian Richard; Karolak, Wlodzimierz; Sidhu, Jagdev Singh; Stagner, Robert Allen; Iyer, Vijay Mohan; Goodson, Gary Wayne; VijayKumar, Akunuri Venkata; Muppirala, Gopal; Dela-Cruz, Myrna A.

Agent Davies Collison Cave

Pub. Number AU-B-2003260336

PCT Number PCT/EP03/08368

PCT Pub. Number WO2004/012741

Priority 0217492.8 29.07.02 GB; 0217493.6 29.07.02 GB; 0313801.3 13.06.03 GB

Filing date 28 July 2003

Wipo publication date 23 February 2004

Acceptance publication date 22 February 2007

International Classifications

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/30 (2006.01) Medicinal preparations characterised by special physical form - Organic coatings

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 7/10 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

20 November 2003 Complete Application Filed

  Priority application(s): 0217492.8 29.07.02 GB; 0217493.6 29.07.02 GB; 0313801.3 13.06.03 GB

1 April 2004 Application Open to Public Inspection

  Published as AU-B-2003260336

22 February 2007 Application Accepted

  Published as AU-B-2003260336

21 June 2007 Standard Patent Sealed

20 December 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 28 Nov 2007. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

29 May 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 28 Nov 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003260337-PYRIDINYL SUBSTITUTED (1,2,3,)TRIAZOLES AS INHIBITORS OF THE TGF-BETA SIGNALLING PATHWAY

2003260335-Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof